Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 2 | 42.8% | +67.4% |
| EBBINGHAUS, BRIANA NOEL | 1 | 62.9% | +61.6% |
| NICOL, ALEXANDER W | 1 | 42.9% | +43.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17624084 | TRANSGENIC MAMMALS AND METHODS OF USE THEREOF | EBBINGHAUS, BRIANA NOEL | 50d overdue |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | NICOL, ALEXANDER W | 61d |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | SINGH, ANOOP KUMAR | 84d |
| 18440340 | LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES | SINGH, ANOOP KUMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17624084 | TRANSGENIC MAMMALS AND METHODS OF USE THEREOF | EBBINGHAUS, BRIANA NOEL | 50d overdue |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | NICOL, ALEXANDER W | 61d |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | SINGH, ANOOP KUMAR | 84d |
| 18440340 | LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES | SINGH, ANOOP KUMAR | — |
| Art Unit | Apps |
|---|---|
| 1632 | 3 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18440340 | LONG GERMLINE DH GENES AND LONG HCDR3 ANTIBODIES | SINGH, ANOOP KUMAR | 1632 | §103§112 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | SINGH, ANOOP KUMAR | 1632 | §102§112 | Non-Final OA | 84d | Pending | Oct 26, 2023 |
| 17624084 | TRANSGENIC MAMMALS AND METHODS OF USE THEREOF | EBBINGHAUS, BRIANA NOEL | 1632 | §102§103§112Other | Final Rejection | 50d overdue | Pending | Dec 30, 2021 |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | NICOL, ALEXANDER W | 1634 | §103§112 | Non-Final OA | 61d | Pending | Jun 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial